Allergen Immunotherapy
Guidance describes unreasonable requests from payors in allergen immunotherapy coding
Demands for additional documentation for claims under Current Procedural Terminology codes 95165, 95115 and 95117 are burdensome and unnecessary, according to guidance published in Annals of Allergy, Asthma & Immunology.
Allergen immunotherapy associated with less nasal inhaler use in the short term
Patients treated with allergen immunotherapy for pollen used less nasal inhaler medication during their first 5 years of treatment than patients who did not use immunotherapy, according to a study published in Allergy.
Subcutaneous allergen immunotherapy reduces asthma risk, improves symptom control
Subcutaneous allergen immunotherapy for house dust mite reduced the number of prescriptions for allergic rhinitis and asthma medications, according to a study published in The European Journal of Allergy and Clinical Immunology.
Allergen immunotherapy shows promise for eosinophilic esophagitis
SAN ANTONIO — Allergen immunotherapy helped to relieve eosinophilic esophagitis symptoms and led to remission, according to results of a systematic review presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Standard, cluster allergen immunotherapy present similar systemic reaction risks
There was no statistical difference in overall risk for systemic reaction between standard and cluster subcutaneous allergen immunotherapy schedules, according to a study published in Annals of Allergy, Asthma & Immunology.
House dust mite immunotherapy shows efficacy in allergic overlap syndrome
LOUISVILLE, Ky. — Allergen-specific immunotherapy showed efficacy among patients with atopic and contact dermatitis overlap syndrome, according to results of a pilot study.
Combination of allergen immunotherapy, tezepelumab relieves nasal symptoms of cat allergy
The addition of tezepelumab to subcutaneous allergen immunotherapy for 1 year improved results in nasal allergen challenges for patients with cat allergies, according to a study published in The Journal of Allergy and Clinical Immunology.
Allergen immunotherapy improves disease severity in atopic dermatitis
Subcutaneous and sublingual immunotherapy for aeroallergens improved disease severity and quality of life among patients with atopic dermatitis, according to a review published in The Journal of Allergy & Clinical Immunology.
Q&A: Study to assess single oral immunotherapy’s ability to treat multiple food allergens
Oral immunotherapy has shown promise in inducing remission of specific food allergies, with one FDA-approved option available for peanut allergy, but these patients often shoulder the burden of multiple food allergies.
Allergen immunotherapy safer with antihistamine premedication
Antihistamine premedication can improve the safety and efficacy of allergen immunotherapy, according to results of a meta-analysis published in Annals of Allergy, Asthma & Immunology.